PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF— quant rating & factor grades
A deterministic quant rating: a 5-level rating (Strong Buy…Strong Sell) and composite grade, plus where this company ranks on each of value, growth, quality and momentum — all as percentiles against Tickwind's tracked US universe. Every figure is engine-computed from SEC XBRL filings and delayed prices, with no LLM. This is a RELATIVE rank within the covered population (the bottom fifth is always Sell-tier by construction), not personalized investment advice.
How the rating works
- Four factor percentiles. Value, Growth, Quality and Momentum are each scored as a percentile (0–100) against Tickwind's tracked US universe — the share of covered stocks this one ranks at or above on that factor's sub-metrics: P/E, P/B, P/S for value (inverted, so cheaper ranks higher); revenue & earnings growth; ROE, ROIC, EBIT margin, Piotroski F for quality; and 1-year total return for momentum.
- Insufficient, never imputed. A sub-metric a stock lacks (or that too few peers report) is skipped — never filled with 0 or a median — and a factor with no computable sub-metric is left absent, never shown as 50.
- A factor needs a real population. A percentile is withheld unless at least 8 tracked stocks carry that sub-metric — ranking against a handful of peers is noise, not a statistic.
- Composite = the mean of the available factor percentiles. A 1-leg composite (only one factor computable) is a far weaker read than a 4-leg one, so the leg count is disclosed.
- Grade = 20-point bands of the composite percentile: A ≥ 80, B ≥ 60, C ≥ 40, D ≥ 20, else F. A plain relabeling of where the percentile falls, lower-inclusive (exactly 80 → A).
- Rating = the same bands, relabeled: Strong Buy ≥ 80, Buy ≥ 60, Hold ≥ 40, Sell ≥ 20, else Strong Sell (A ⇔ Strong Buy … F ⇔ Strong Sell).
- It is RELATIVE, by construction. The rating ranks this stock within the covered population, so the bottom fifth is always Sell-tier no matter its absolute fundamentals. It is a quantitative model over the disclosed population — not personalized investment advice.
This page is a deterministic relative quantitative-model rating — not personalized investment advice, a price target or a forecast. Source: SEC XBRL filings and delayed prices; for reference only.